EMS Runs for Suspected Opioid Overdose: Implications for Surveillance and Prevention

References

• Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. National Survey on Drug Use and Health Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Rockville, MD: SAMHSA, February 5, 2009.
   Google Scholar
• Kochanek KD, Xu J, Murphy SL, Deaths: final data for 2009. National Vital Statistics Reports;60(3). Hyattsville, MD: National Center for Health Statistics, 2012.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08–4343). Rockville, MD: SAMHSA, 2008.
   Google Scholar
• Smyth B, Hoffman V, Fan J, Hser YI. Years of potential life lost among heroin addicts 33 years after treatment. Prev Med. 2007;44:369–74.
   PubMed Web of Science ®Google Scholar
• Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010;38:517–24.
   PubMed Web of Science ®Google Scholar
• Hall AJ, Logan JE, Toblin RL, Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–20.
   PubMed Web of Science ®Google Scholar
• Schneider MF, Bailey JE, Cicero TJ, Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf. 2009;18:778–90.
   PubMed Web of Science ®Google Scholar
• Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Assessing opioid shopping behaviour: a large cohort study from a medication dispensing database in the US. Drug Saf. 2012;35:325–34.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Drug Abuse Warning Network 2006: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-30, DHHS Publication No. (SMA) 08-4339. Rockville, MD: SAMHSA, 2008.
   Google Scholar
• Merchant RC, Schwartzapfel BL, Wolf FA, Li W, Carlson L, Rich JD. Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997–2002. Subst Use Misuse. 2006;41:1209–26.
   PubMed Web of Science ®Google Scholar
• Dietze P, Fry C, Sunjic S, Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose. Drug Alcohol Depend. 2002;67:99–103.
   PubMed Web of Science ®Google Scholar
• Seidler D, Schmeiser-Rieder A, Schlarp O, Laggner AN. Heroin and opiate emergencies in Vienna: analysis at the municipal ambulance service. J Clin Epidemiol. 2000;53:734–41.
   PubMed Web of Science ®Google Scholar
• Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15:320–4.
   PubMed Web of Science ®Google Scholar
• Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004;11:19–23.
   PubMed Web of Science ®Google Scholar
• Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3: 183–6.
   PubMedGoogle Scholar
• Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14:616–23.
   PubMed Web of Science ®Google Scholar
• Dietze P, Jolley D, Cvetkovski S, Cantwell K, Jacobs I, Indig D. Characteristics of non-fatal opioid overdoses attended by ambulance services in Australia. Aust N Z J Public Health. 2004;28:569–75.
   PubMed Web of Science ®Google Scholar
• Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104:2067–74.
   PubMed Web of Science ®Google Scholar
• Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, Page K. Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol. 2012;175:302–8.
   PubMed Web of Science ®Google Scholar
• Gilson AM. The concept of addiction in law and regulatory policy related to pain management: a critical review. Clin J Pain. 2010;26:70–7.
   PubMed Web of Science ®Google Scholar
• Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83:104–10.
   PubMed Web of Science ®Google Scholar
• Togia A, Sergentanis TN, Sindos M, Drug abuse-related emergency calls: a metropolis-wide study. Prehosp Disaster Med. 2008;23:36–40.
   PubMedGoogle Scholar
• Tracy M, Piper TM, Ompad D, Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005;79:181–90.
   PubMed Web of Science ®Google Scholar
• Baca CT, Grant KJ. What heroin users tell us about overdose. J Addict Dis. 2007;26(4):63–8.
   PubMed Web of Science ®Google Scholar
• Maryland Institute for Emergency Medical Services Systems. The Maryland Medical Protocols for Emergency Medical Services Providers. MIEMSS; 2008:348. Available at: http://www.miemss.org/home/LinkClick.aspx?fileticket= PcFzAVnOA4M%3d&tabid=106&mid=537. Accessed May 9, 2013.
   Google Scholar
• Office of Epidemiology and Planning. Intoxication Deaths Associated with Drugs of Abuse or Alcohol. 2009 Final Report . Baltimore City, MD: Baltimore City Health Department, and Baltimore Substance Abuse Systems, July 2011. Available at: http://www.baltimorehealth.org/info/DOA%20Final%20 Report%202009--Final.pdf. Accessed May 9, 2013.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network: Area profiles of drug-related mortality. DHHS Publication No. (SMA). SMA10-4473. Rockville, MD: SAMHSA, 2008.
   Google Scholar
• Yacoubian GS, Hsu M, Wish ED. Estimating the Need for Substance Abuse Treatment in Maryland: An Update of Reuter et al. (1998). College Park, MD: Center for Substance Abuse Research (CESAR), University of Maryland, 2002.
   Google Scholar
• Friedman SR, Tempalski B, Cooper H, Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377–400.
   PubMed Web of Science ®Google Scholar
• Maryland Institute for Emergency Medical Services Systems. EMAIS User Manual 3.0. Baltimore, MD: MIEMSS, 21. Available at: http://www.miemss.org/home/LinkClick. aspx?fileticket=AZFED0if7jQ%3d&tabid=54. Accessed April 14, 2013.
   Google Scholar
• U.S. Census Bureau. Preliminary Annual Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico: April 1, 2000 to July 1, 2010 (NST-PEST2010-01). Available at: http://www.census.gov/popest/research/eval-estimates/eval-est2010.html. Accessed May 9, 2013.
   Google Scholar
• Microsoft Corporation. Microsoft Office Access 11.5. Redmond, WA, 2003.
   Google Scholar
• IBM Corporation. SPSS 19.0, Armonk, NY.
   Google Scholar
• StataCorp. Stata Statistical Software: Release 10.1. College Station, TX.
   Google Scholar
• Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet. 1961;25:83–7.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. State Estimates of Substance Use and Mental Disorders from the 2008–2009 National Surveys on Drug Use and Health, NSDUH Series H-40; DHHS Publication No. (SMA) 11–4641. Rockville, MD: SAMHSA, 2011.
   Google Scholar
• Phillips DP, Christenfeld N, Ryan NM. An increase in the number of deaths in the United States in the first week of the month—an association with substance abuse and other causes of death. N Engl J Med. 1999;341:93–8.
   PubMed Web of Science ®Google Scholar
• Hoffman JR, Schriger DL, Luo JS. The empiric use of naloxone in patients with altered mental status: a reappraisal. Ann Emerg Med. 1991;20:246–52.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (IOM). Emergency Medical Services: At the Crossroads. Washington, DC: National Academies Press, 2007.
   Google Scholar
• Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;101:1797–804.
   PubMed Web of Science ®Google Scholar
• Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–6.
   PubMed Web of Science ®Google Scholar
• Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. “The life they save may be mine”: diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20:137–42.
   PubMed Web of Science ®Google Scholar
• Baca CT, Grant KJ Take-home naloxone to reduce heroin death. Addiction. 2005;100:1823–31.
   PubMed Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87:931–41.
   PubMed Web of Science ®Google Scholar
• George S, Boulay S, Begley D. ‘I saved a life’: a heroin addict's reflections on managing an overdose using ‘take home naloxone’. BMJ Case Rep. Sep 7;2010.
   Google Scholar